Clinical Trial Update: MTS109 in Patients With Refractory Autoimmune Diseases [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating MTS109 in adults with refractory autoimmune diseases is currently recruiting. The study includes systemic lupus erythematosu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anca-associated Vasculitis
• Idiopathic Inflammatory Myopathies
• Sjögren Syndrome
• Systemic Lupus Erythematosus
• Systemic Sclerosis

Drugs mentioned

• MTS109

Snippet

Sponsor: Shanghai Changzheng Hospital | Conditions: Systemic Lupus Erythematosus, Idiopathic Inflammatory Myopathies | EARLY_Phase 1 | Status: RECRUITING